Benadryl and Cabergoline drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Benadryl and Cabergoline. Common interactions include deformity among females and depression among males.

The phase IV clinical study analyzes what interactions people who take Benadryl and Cabergoline have. It is created by eHealthMe based on reports of 24 people who take Benadryl and Cabergoline from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Feb, 07, 2023

24 people who take Benadryl and Cabergoline together, and have interactions are studied.

What is Benadryl?

Benadryl has active ingredients of diphenhydramine hydrochloride. It is often used in allergies. eHealthMe is studying from 89,762 Benadryl users for its effectiveness, alternative drugs and more.

What is Cabergoline?

Cabergoline has active ingredients of cabergoline. It is often used in prolactinoma. eHealthMe is studying from 5,457 Cabergoline users for its effectiveness, alternative drugs and more.

Number of Benadryl and Cabergoline reports submitted per year:

Common Benadryl and Cabergoline drug interactions by gender *:

female:

Deformity
Dementia
Depressed mood
Depression
Dermatitis
Diabetes mellitus inadequate control
Diabetic gastropathy
Diabetic ketoacidosis
Diabetic neuropathy
Diarrhoea

male:

Depression
Nausea
Benign prostatic hyperplasia
Bronchitis
Cardiac tamponade
Cardiomegaly
Chronic kidney disease
Contusion
Cough
Dizziness

Common Benadryl and Cabergoline drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

Abdominal pain
Drug ineffective
Muscle spasms
Nausea
Vitamin d deficiency

30-39:

n/a

40-49:

Arthralgia
Depression
Knee arthroplasty
Pain in extremity
Peripheral swelling
Post procedural infection
Suicidal ideation
Abdominal distension
Abdominal pain
Anxiety

50-59:

Hospitalisation

60+:

Acute myeloid leukaemia recurrent
Amnesia
Depression
Dizziness
Dyspnoea
Dyspnoea exertional
Emphysema
Febrile neutropenia
Haemoglobin decreased
Hospitalisation

Common conditions people have *:

Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 5 people, 20.83%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 5 people, 20.83%
Abdominal Discomfort: 4 people, 16.67%
Flatulence (flatus expelled through the anus): 4 people, 16.67%
Abdominal Distension: 4 people, 16.67%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 4 people, 16.67%
Rashes (redness): 3 people, 12.50%
Multiple Allergies (allergy to multiple agents): 3 people, 12.50%
High Blood Cholesterol: 3 people, 12.50%
Abdominal Pain: 2 people, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Benadryl and Cabergoline?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related publications that referenced our studies

Gürbüz F, Ya?c?-Küpeli B, K?r Y, Yüksel B, Zorludemir S, Gürbüz BB, Küpeli S, "The first report of cabergoline-induced immune hemolytic anemia in an adolescent with prolactinoma", Journal of Pediatric Endocrinology and Metabolism, 2014 Jan .
Harris YT, Harris AZ, "Cabergoline associated with first episode mania", Psychosomatics, 2012 Jan .

Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Benadryl (89,762 reports)
Cabergoline (5,457 reports)